Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Keratin 8 pseudogene 44 (KRT8P44)** is classified as a *pseudogene* in the human genome, identifiable by the gene symbol KRT8P44 and NCBI Gene ID 100129958[5][7][8]. Unlike protein-coding genes, pseudogenes are genomic sequences resembling functional genes but are typically nonfunctional due to mutations or insufficient regulatory elements and do not generally encode functional proteins. KRT8P44 is part of the broader keratin gene family, which includes functional genes like keratin 8 (KRT8), an intermediate filament protein important in the structural integrity of epithelial cells[3][4]. However, as a pseudogene, KRT8P44 is not known to carry out any biological function, is not implicated as a disease-causing gene, is not a therapeutic target, and is not associated with known drugs, disease roles, mechanisms of action, biomarkers, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 44 (KRT8P44).